Ming Qing Li

6785846, Aug 31, 2004

Dec 22, 2000

09/742372

Ming Y. Li - Mahwah NJ

Intel Corporation - Santa Clara CA

G06F 1100

714 30, 714 36, 714733

A system and method is provided for detecting defects in an embedded architecture or micro-processor based system. A look-up table, located with in a programmable logic device, is accessed to obtain a value for a particular byte of a predetermined data pattern. The predetermined data pattern is associated with data from a bus coupled to the programmable logic device. The accessed value of the predetermined data pattern is compared to data that is received by the programmable logic device from a memory coupled to the programmable logic device via the bus. An alarm mechanism, to indicate an improper data comparison, is triggered based upon the comparison of the predetermined data pattern and the data received from the memory.

8588810, Nov 19, 2013

Nov 30, 2011

13/307754

Jing Dai - White Plains NY, US
Ming Li - Elmsford NY, US
Milind R. Naphade - Fishkill NY, US
Sambit Sahu - Hopewell Junction NY, US

International Business Machines Corporation - Armonk NY

H04W 24/00

4554561, 455 412, 4554042, 4554562, 4554563, 4554566

A GPS-enabled cellular electronic device is operated in an indoor mode. An increase in strength of a cellular signal is detected at the GPS-enabled cellular electronic device. Responsive at least to the increase in cellular signal strength, the GPS-enabled cellular electronic device is transitioned to an outdoor testing mode. Detecting is carried out to determine whether movement of the GPS-enabled cellular electronic device occurs during the outdoor testing mode. If so, the GPS-enabled cellular electronic device is transitioned to an outdoor mode.

20100227795, Sep 9, 2010

Mar 3, 2009

12/397219

Solomon S. Steiner - Mount Kisco NY, US
Ming Li - Yorktown Heights NY, US
Robert Hauser - Columbia MD, US

A61K 38/28
A61P 3/10

514 3

Injectable insulin formulations with improved stability and rapid onset of action are described herein. The formulations may be for subcutaneous, intradermal or intramuscular administration. In the preferred embodiment, the formulations are administered via subcutaneous injection. The formulations contain insulin in combination with a chelator and dissolution agent, and optionally additional excipients. In the preferred embodiment, the formulation contains human insulin, a zinc chelator such as EDTA and a dissolution agent such as citric acid or sodium citrate. These formulations are rapidly absorbed into the blood stream when administered by subcutaneous injection. In the preferred embodiment, the insulin is provided as a clear liquid, neutral pH, in a multi-use sterile vial. In an alternative embodiment, the insulin is provided as a powder in a sterile vial. This is mixed with a diluent containing a pharmaceutically acceptable carrier, such as water, a zinc chelator such as EDTA and a dissolution agent such as citric acid shortly before or at the time of administration. In another embodiment, the insulin is stored as a frozen mixture, ready for use upon thawing.

20110097386, Apr 28, 2011

Mar 1, 2010

12/715203

Solomon S. Steiner - Mount Kisco NY, US
Robert Hauser - Columbia MD, US
Ming Li - Yorktown Heights NY, US
Robert Feldstein - Yonkers NY, US

A61K 38/26
A61K 9/127
A61P 3/08

424450, 514 117

A formulation composed of a sugar such as glucose and a surfactant such as myristoyl lysophosphocholine (LMPC) has been designed to stabilize both hydrophilic and hydrophobic portions of the glucagon molecule, under prolonged physiological conditions, in a formulation that is sufficiently similar to the pH and osmolarity of plasma so as not to induce or to minimize site irritation. The combination of a simple sugar and an surfactant stabilizes the glucagon molecule in an aqueous solution for seven days at 37 C.

20110237510, Sep 29, 2011

Sep 27, 2010

12/891240

Solomon S. Steiner - Mount Kisco NY, US
Robert Hauser - Columbia MD, US
Ming Li - Yorktown Heights NY, US
Robert Feldstein - Yonkers NY, US

A61K 38/26
A61P 3/08
B65D 85/00

514 117, 2065241

A formulation composed of a sugar such as glucose and a surfactant such as myristoyl lysophosphocholine (LMPC) has been designed to stabilize both hydrophilic and hydrophobic portions of the glucagon molecule, under prolonged physiological conditions, in a formulation that is sufficiently similar to the pH and osmolarity of plasma so as not to induce or to minimize site irritation. The combination of a simple sugar and an surfactant stabilizes the glucagon molecule in an aqueous solution for seven days at 37 C.

20120178675, Jul 12, 2012

Jul 5, 2011

13/176435

Solomon Steiner - Mount Kisco NY, US
Robert Hauser - Columbia MD, US
Richard Seibert - Carmel NY, US
Ming Li - Yorktown Heights NY, US

A61K 38/28
A61P 25/00
A61P 3/10

514 64

Compositions and methods for modulating the pharmacokinetics and pharmacodynamics of rapid acting injectable insulin formulations are described herein. In the preferred embodiment, the formulations are administered via subcutaneous injection. The formulations contain insulin in combination with a zinc chelator such as ethylenediaminetetraacetic acid (“EDTA”) and a dissolution/stabilization agent, and optionally additional excipients. Calcium disodium EDTA is less likely to remove calcium from the body, and typically has less pain on injection in the subcutaneous tissue. Modulating the type and quantity of EDTA can change the insulin absorption profile. Increasing the quantity of citrate can further enhance absorption and chemically stabilize the formulation. In the preferred embodiment, the formulation contains human insulin, calcium disodium EDTA and a dissolution/stabilization agent such as citric acid or sodium citrate. These formulations are rapidly absorbed into the blood stream when administered by subcutaneous injection.

20120191856, Jul 26, 2012

Jan 26, 2011

13/014501

HAN CHEN - White Plains NY, US
Minkyong Kim - Scarsdale NY, US
Hui Lei - Scarsdale NY, US
Ming Li - Elmsford NY, US
Fan Ye - Yorktown Heights NY, US

INTERNATIONAL BUSINESS MACHINES CORPORATION - ARMONK NY

G06F 15/173

709226

A system and method are disclosed for an elastic and scalable publish/subscribe scheme. Subscription information is received at a dispatcher node. A plurality of matching nodes are selected in an overlay network to store the subscription information on a computer readable storage medium. Upon receiving an event at a dispatching node, at least one of the matching nodes with the stored subscription information is selected to process the event.

20120310758, Dec 6, 2012

Jun 1, 2011

13/150350

Kun Bai - Elmsford NY, US
Ming Li - Elmsford NY, US
Leslie S. Liu - White Plains NY, US
Fan Ye - Ossining NY, US
Liangzhao Zeng - Mohegan Lake NY, US
Xinxin Zhu - Croton on Hudson NY, US

INTERNATIONAL BUSINESS MACHINES CORPORATION - Armonk NY

G06Q 30/00

705 23, 705 267, 705 2661

Techniques for guideline-based food purchase management are provided. The techniques include generating a personalized set of nutrition guidelines for a user, generating a user profile for the user, wherein the user profile comprises health information and nutrition preferences, and using the personalized set of nutrition guidelines and the user profile to generate a guideline-based shopping list for the user. Techniques for generating location-based food purchase guidance are also provided. The techniques include obtaining a shopping list of food items and a list of stores to be considered in connection with the food items on the shopping list, using the shopping list, list of stores, a store location map and inter-store routing guidance to generate an inter-store shopping route, and generating an in-store shopping route, for each of the stores in the inter-store shopping route, based on the shopping list, intra-store routing guidance and a floor plan for the store.